Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.190
-0.020 (-1.65%)
At close: May 9, 2025, 4:00 PM
1.210
+0.020 (1.68%)
After-hours: May 9, 2025, 7:55 PM EDT
Humacyte Market Cap
Humacyte has a market cap or net worth of $184.59 million as of May 9, 2025. Its market cap has decreased by -60.56% in one year.
Market Cap
184.59M
Enterprise Value
221.02M
1-Year Change
-60.56%
Ranking
Category
Stock Price
$1.19
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $184.59M, an increase of 48.50%. That is a compound annual growth rate of 9.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2025 | 187.69M | -71.11% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | 130.74M | 5.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 674.60B |
| Johnson & Johnson | 374.53B |
| UnitedHealth Group | 349.75B |
| AbbVie | 328.29B |
| Novo Nordisk | 287.72B |
| Abbott Laboratories | 233.14B |
| Novartis AG | 215.89B |
| AstraZeneca | 208.98B |